All stock lists
Gyre Therapeutics, Inc. (NASDAQ:GYRE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
4.28-0.37 (-7.97%)
Market cap
$454M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 12, 2006
Website
Insider Score
––Not scored
GYRE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
GYRE Stock Insider Trading Activity
GYRE stock’s insider trading shows 8 sales on the open market for an estimated $433.42K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Ye Weiguo Chief Operating Officer | Sell | 3,000 | $6.35 | $19.05K | — | 700,000 | Jun 18, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Option exercise | 3,000 | $0.75 | $2.25K | New | 703,000 | Jun 18, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Sell | 2,800 | $6.17 | $17.28K | — | 700,000 | Jun 11, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Option exercise | 2,800 | $0.75 | $2.10K | New | 702,800 | Jun 11, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Sell | 6,418 | $6.21 | $39.86K | — | 700,000 | Jun 10, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Option exercise | 6,418 | $0.75 | $4.81K | New | 706,418 | Jun 10, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Sell | 5,000 | $6.24 | $31.20K | — | 700,000 | Jun 10, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Option exercise | 5,000 | $0.75 | $3.75K | New | 705,000 | Jun 10, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Sell | 14,500 | $6.14 | $89.03K | — | 700,000 | Jun 9, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Option exercise | 14,500 | $0.75 | $10.88K | New | 714,500 | Jun 9, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Sell | 3,000 | $6.15 | $18.45K | — | 700,000 | Jun 9, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Option exercise | 3,000 | $0.75 | $2.25K | New | 703,000 | Jun 9, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Sell | 15,401 | $6.40 | $98.57K | — | 700,000 | Jun 5, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Option exercise | 15,401 | $0.75 | $11.55K | New | 715,401 | Jun 5, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Sell | 19,575 | $6.13 | $119.99K | — | 700,000 | Jun 4, 2026 | — | Form 4 |
| Ye Weiguo Chief Operating Officer | Option exercise | 19,575 | $0.75 | $14.68K | New | 719,575 | Jun 4, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.